Skip to content

Total Pancreatectomies in Germany - Epidemiology, Trends,

A Nationwide Analysis of Total Pancreatectomy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06466928
Acronym
ToPaGe
Enrollment
12938
Registered
2024-06-20
Start date
2010-01-01
Completion date
2024-06-05
Last updated
2024-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreas Disease

Keywords

Specialization, Pancreatic Surgery, Total Resection, Volume-Outcome-Relationship

Brief summary

The purpose of this study was to evaluate the real-world mortality rates of total pancreatectomy across Germany and to understand the impact of hospital caseload on surgical outcomes.

Detailed description

This retrospective observational study analyzed routine data from the nationwide German diagnosis-related group statistics, covering the years 2010 to 2020. The data included all inpatient episodes from acute care hospitals. The study focused on mortality rates associated with total pancreatectomy and examined how these rates varied with the complexity of the surgeries and the volume of procedures performed by different hospitals. The mortality rates for total pancreatectomy in Germany were found to be more than three times higher than those reported by specialized pancreatic centers. Mortality rates increased significantly with the complexity of the total pancreatectomy procedures, especially those involving arterial resections. Hospitals with lower total pancreatectomy caseloads had higher mortality rates compared to high-volume centers. Results showed that total pancreatectomies are associated with high mortality rates, particularly in hospitals with lower surgical volumes. The findings suggest that the promising outcomes from specialized centers cannot be generalized to all hospitals performing pancreatic surgeries, highlighting the need for a thorough understanding of the learning curve and specialization in pancreatic surgery to reduce mortality risks.

Interventions

Surgical removal of the entire pancreas

Sponsors

Margarete-Ammon-Stiftung
CollaboratorUNKNOWN
Medizinische Hochschule Brandenburg Theodor Fontane
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* total pancreatectomy between January 2010 and December 2020 * 18 years or older

Exclusion criteria

* postmortem pancreatectomy (OPS code 5-525.4) * removal of a pancreas transplant (OPS code 5-525.3)

Design outcomes

Primary

MeasureTime frameDescription
In-hospital mortality30 daysDeath

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026